| |
|
|
| Name: |
Affinity Asset Advisors LLC |
| City: |
Bridgehampton |
| State: |
NY |
| Zip: |
11932 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
79 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
IMGN |
Immunogen Inc |
1 |
New |
$31.23 |
$41,647,000 |
1,404,608 |
8.79% |
41,647,000 |
1,404,608 |
0.636 |
Drug Manufacturers - ... |
|
|
CERE |
Cerevel Therapeutics Holdin... |
2 |
- |
$42.47 |
$31,800,000 |
750,000 |
6.71% |
16,845,000 |
64,939 |
0.48 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
3 |
- |
$32.48 |
$25,756,000 |
1,090,441 |
5.43% |
8,917,000 |
-38,935 |
1.151 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
4 |
- |
$193.33 |
$23,138,000 |
100,000 |
4.88% |
10,725,000 |
15,000 |
0.603 |
Diagnostic Substances |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
5 |
- |
$0.00 |
$21,188,000 |
460,000 |
4.47% |
10,925,000 |
159,562 |
0.736 |
N/A |
|
|
TEVA |
Teva Pharmaceutical Industr... |
6 |
- |
$13.81 |
$19,836,000 |
1,900,000 |
4.19% |
-564,000 |
-100,000 |
0.173 |
Drug Manufacturers - ... |
|
|
ACLX |
Arcellx, Inc. |
7 |
- |
$0.00 |
$18,870,000 |
340,000 |
3.98% |
4,518,000 |
-60,000 |
0.694 |
N/A |
|
|
LIAN |
Lianbio |
8 |
- |
$0.00 |
$16,895,000 |
3,779,694 |
3.56% |
15,893,000 |
3,107,337 |
3.525 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
9 |
- |
$42.12 |
$15,908,000 |
447,095 |
3.36% |
2,525,000 |
-2,905 |
0.771 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
10 |
- |
$36.30 |
$15,864,000 |
400,000 |
3.35% |
11,736,000 |
250,000 |
0.764 |
Diagnostic Substances |
|
|
APGE |
Apogee Therapeutics, Inc. |
11 |
- |
$47.13 |
$15,006,000 |
537,093 |
3.17% |
-7,255,000 |
-508,017 |
1.444 |
N/A |
|
|
IMVT |
Immunovant Inc |
12 |
- |
$0.00 |
$14,535,000 |
345,000 |
3.07% |
3,018,000 |
45,000 |
0.396 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
13 |
- |
$65.34 |
$13,358,000 |
160,000 |
2.82% |
6,571,000 |
-70,366 |
0.141 |
Biotechnology |
|
|
NUVL |
Nuvalent, Inc. |
14 |
- |
$0.00 |
$12,878,000 |
175,000 |
2.72% |
10,579,000 |
125,000 |
0.307 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
15 |
- |
$9.00 |
$11,262,000 |
1,466,465 |
2.38% |
3,800,000 |
466,165 |
5.912 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
16 |
- |
$0.00 |
$11,209,000 |
563,824 |
2.36% |
5,205,000 |
195,495 |
0.769 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
17 |
- |
$0.60 |
$11,138,000 |
517,554 |
2.35% |
8,170,000 |
275,257 |
0.846 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
18 |
- |
$4.00 |
$9,985,000 |
1,550,408 |
2.11% |
5,343,000 |
-442,058 |
0.896 |
N/A |
|
|
ALKS |
Alkermes Plc |
19 |
- |
$24.68 |
$9,886,000 |
356,384 |
2.09% |
7,085,000 |
256,384 |
0.217 |
Drug Delivery |
|
|
INZY |
Inozyme Pharma, Inc. |
20 |
- |
$0.00 |
$8,034,000 |
1,885,802 |
1.7% |
2,239,000 |
505,950 |
3.053 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
21 |
- |
$0.00 |
$7,122,000 |
690,112 |
1.5% |
5,157,000 |
440,112 |
1.467 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
22 |
- |
$0.00 |
$6,334,000 |
795,729 |
1.34% |
-253,000 |
-222,362 |
0.91 |
N/A |
|
|
ESTA |
Establishment Labs Holdings... |
23 |
- |
$48.47 |
$5,910,000 |
228,277 |
1.25% |
-5,823,000 |
-10,831 |
0.974 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
24 |
- |
$58.70 |
$5,878,000 |
100,049 |
1.24% |
3,246,000 |
39,623 |
0.149 |
Biotechnology |
|
|
ROIV |
Roivant Sciences Ltd. |
25 |
- |
$11.03 |
$5,615,000 |
500,000 |
1.18% |
3,863,000 |
350,000 |
0.072 |
N/A |
|
|
VKTX |
Viking Therapeutics, Inc. |
26 |
- |
$74.31 |
$5,583,000 |
300,000 |
1.18% |
2,262,000 |
0 |
0.411 |
N/A |
|
|
SVRA |
Savara Inc |
27 |
- |
$4.41 |
$5,405,000 |
1,150,000 |
1.14% |
1,058,000 |
0 |
1.01 |
Biotechnology |
|
|
CMPS |
Compass Pathways Plc |
28 |
New |
$0.00 |
$4,813,000 |
550,000 |
1.02% |
4,813,000 |
550,000 |
1.58 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
29 |
- |
$49.86 |
$4,490,000 |
75,000 |
0.95% |
2,968,000 |
35,000 |
0.066 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
30 |
- |
$0.00 |
$4,287,000 |
70,988 |
0.9% |
1,437,000 |
20,988 |
0.173 |
N/A |
|
|
DVAX |
Dynavax Technologies Corp |
31 |
- |
$11.21 |
$4,194,000 |
300,000 |
0.88% |
1,240,000 |
100,000 |
0.223 |
Drug Manufacturers - ... |
|
|
AZN |
AstraZeneca Plc (ADR) |
32 |
- |
$75.17 |
$4,041,000 |
60,000 |
0.85% |
-22,000 |
0 |
0.002 |
Drug Manufacturers - ... |
|
|
AXSM |
Axsome Therapeutics, Inc. |
33 |
- |
$71.71 |
$3,980,000 |
50,000 |
0.84% |
3,980,000 |
50,000 |
0.134 |
N/A |
|
|
SWTX |
Springworks Therapeutics, Inc. |
34 |
- |
$0.00 |
$3,650,000 |
100,000 |
0.77% |
2,689,000 |
58,419 |
0.144 |
N/A |
|
|
RLAY |
Relay Therapeutics, Inc. |
35 |
New |
$6.37 |
$3,303,000 |
300,000 |
0.7% |
3,303,000 |
300,000 |
0.222 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
36 |
- |
$24.88 |
$3,230,000 |
80,000 |
0.68% |
2,439,000 |
50,000 |
0.05 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
37 |
- |
$156.88 |
$3,102,000 |
25,000 |
0.65% |
-3,568,000 |
-32,500 |
0.1 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
38 |
New |
$0.00 |
$3,057,000 |
300,000 |
0.64% |
3,057,000 |
300,000 |
0.689 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
39 |
- |
$0.00 |
$2,973,000 |
300,274 |
0.63% |
-968,000 |
-49,726 |
0.343 |
N/A |
|
|
ARGX |
Argenx Se |
40 |
New |
$372.80 |
$2,853,000 |
7,500 |
0.6% |
2,853,000 |
7,500 |
0.016 |
N/A |
|
|
KURA |
Kura Oncology Inc |
41 |
- |
$19.65 |
$2,754,000 |
191,535 |
0.58% |
-5,058,000 |
-665,000 |
0.251 |
N/A |
|
|
EYPT |
EyePoint Pharmaceuticals Inc |
42 |
New |
$0.44 |
$2,540,000 |
109,900 |
0.54% |
2,540,000 |
109,900 |
0.077 |
Biotechnology |
|
|
ASND |
Ascendis Pharma AS |
43 |
- |
$135.90 |
$2,519,000 |
20,000 |
0.53% |
-1,826,000 |
-26,400 |
0.031 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
44 |
- |
$2.94 |
$2,320,000 |
1,000,000 |
0.49% |
-1,300,000 |
-1,850,000 |
0.892 |
N/A |
|
|
IMTX |
Immatics N.V |
45 |
- |
$10.01 |
$2,106,000 |
200,000 |
0.44% |
-210,000 |
0 |
0.318 |
N/A |
|
|
PEN |
Penumbra Inc |
46 |
New |
$204.41 |
$1,887,000 |
7,500 |
0.4% |
1,887,000 |
7,500 |
0.021 |
N/A |
|
|
TRML |
Tourmaline Bio |
47 |
- |
$0.00 |
$1,782,000 |
68,081 |
0.38% |
658,000 |
-331,919 |
0.165 |
N/A |
|
|
ADCT |
ADC Therapeutics Sa |
48 |
- |
$4.34 |
$1,682,000 |
1,013,540 |
0.35% |
695,000 |
-86,460 |
1.433 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
49 |
- |
$0.00 |
$1,570,000 |
25,000 |
0.33% |
295,000 |
0 |
0.023 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
50 |
- |
$10.78 |
$1,543,000 |
125,969 |
0.33% |
-1,137,000 |
-152,323 |
0.373 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
51 |
- |
$0.00 |
$1,476,000 |
50,000 |
0.31% |
528,000 |
20,000 |
0.136 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
52 |
- |
$0.00 |
$1,396,000 |
125,000 |
0.29% |
240,000 |
0 |
0.153 |
N/A |
|
|
NBIX |
Neurocrine Biosciences Inc |
53 |
New |
$135.99 |
$1,318,000 |
10,000 |
0.28% |
1,318,000 |
10,000 |
0.011 |
Biotechnology |
|
|
NARI |
Inari Medical, Inc. |
54 |
New |
$0.00 |
$1,298,000 |
20,000 |
0.27% |
1,298,000 |
20,000 |
0.039 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
55 |
New |
$0.00 |
$1,284,000 |
400,000 |
0.27% |
1,284,000 |
400,000 |
0.285 |
N/A |
|
|
MORF |
Morphic Holding, Inc. |
56 |
- |
$28.07 |
$1,232,000 |
42,670 |
0.26% |
-4,954,000 |
-227,330 |
0.111 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
57 |
New |
$12.88 |
$1,089,000 |
50,000 |
0.23% |
1,089,000 |
50,000 |
0.11 |
N/A |
|
|
BHVN |
Biohaven Ltd. |
58 |
- |
$38.97 |
$893,000 |
20,866 |
0.19% |
109,000 |
-9,290 |
0.031 |
N/A |
|
|
PBYI |
Puma Biotechnology Inc |
59 |
- |
$5.02 |
$876,000 |
202,349 |
0.18% |
344,000 |
0 |
0.509 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
60 |
New |
$0.00 |
$844,000 |
125,000 |
0.18% |
844,000 |
125,000 |
0.198 |
N/A |
|
|
AVRO |
Averion International Corp |
61 |
- |
$1.21 |
$680,000 |
500,000 |
0.14% |
-90,000 |
0 |
1.372 |
Biotechnology |
|
|
IMTXW |
Immatics N.V - Warrants |
62 |
- |
$0.00 |
$547,000 |
187,204 |
0.12% |
-116,000 |
0 |
2.08 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
63 |
- |
$4.91 |
$428,000 |
66,000 |
0.09% |
-1,207,000 |
-259,000 |
0.118 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
64 |
- |
$10.42 |
$378,000 |
250,000 |
0.08% |
43,000 |
0 |
0.115 |
N/A |
|
|
CNTX |
Context Therapeutics Inc. |
65 |
- |
$0.00 |
$372,000 |
328,817 |
0.08% |
-125,000 |
0 |
2.06 |
N/A |
|
|
IFRX |
InflaRx NV |
66 |
- |
$1.33 |
$326,000 |
200,097 |
0.07% |
-643,000 |
-125,000 |
0.855 |
N/A |
|
|
PMN |
Promis Neurosciences Ord Shs |
67 |
- |
$1.98 |
$306,000 |
265,958 |
0.06% |
-221,000 |
0 |
3.1 |
N/A |
|
|
ARAV |
Aravive Inc |
68 |
- |
$0.04 |
$43,000 |
346,511 |
0.01% |
-3,000 |
0 |
1.789 |
N/A |
|
|
BCAB |
Bioatla, Inc. |
73 |
Closed |
$0.00 |
$0 |
0 |
0% |
-306,000 |
-180,000 |
0 |
N/A |
|
|
NLSP |
Nls Pharmaceutics Ord Shs |
79 |
Closed |
$0.00 |
$0 |
0 |
0% |
-140,000 |
-200,455 |
0 |
N/A |
|
|
PRTA |
Prothena Corp Plc |
72 |
Closed |
$20.87 |
$0 |
0 |
0% |
-3,822,000 |
-79,214 |
0 |
N/A |
|
|
MIST |
Milestone Pharmaceuticals Inc. |
78 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,039,000 |
-335,068 |
0 |
N/A |
|
|
TVTX |
Travere Therapeutics, Inc |
71 |
Closed |
$5.26 |
$0 |
0 |
0% |
-894,000 |
-100,000 |
0 |
N/A |
|
|
LNTH |
Lantheus Holdings, Inc. |
77 |
Closed |
$65.56 |
$0 |
0 |
0% |
-2,084,000 |
-30,000 |
0 |
N/A |
|
|
THRX |
Theseus Pharmaceuticals, Inc. |
70 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,078,000 |
-400,726 |
0 |
N/A |
|
|
ALDX |
Aldeyra Therapeutics, Inc. |
76 |
Closed |
$3.93 |
$0 |
0 |
0% |
-296,000 |
-44,348 |
0 |
N/A |
|
|
SGEN |
Seagen Inc |
69 |
Closed |
$228.74 |
$0 |
0 |
0% |
-2,122,000 |
-10,000 |
0 |
Biotechnology |
|
|
PODD |
Insulet Corp |
75 |
Closed |
$166.19 |
$0 |
0 |
0% |
-797,000 |
-5,000 |
0 |
Medical Instruments &... |
|
|
INSP |
Inspire Medical Systems Inc |
74 |
Closed |
$237.45 |
$0 |
0 |
0% |
-1,249,000 |
-6,293 |
0 |
N/A |
|
